DFDMX | RPMGX | DFDMX / RPMGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 32 years | - |
Gain YTD | 13.051 | 9.466 | 138% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 418M | 31B | 1% |
Annual Yield % from dividends | 0.00 | 0.05 | - |
Returns for 1 year | 27.06 | 14.13 | 192% |
Returns for 3 years | -9.72 | -18.72 | 52% |
Returns for 5 years | 39.73 | 13.50 | 294% |
Returns for 10 years | 134.61 | 35.50 | 379% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SBMAX | 36.94 | -0.39 | -1.04% |
ClearBridge Mid Cap A | |||
TLATX | 13.72 | -0.18 | -1.29% |
Transamerica Large Core ESG I3 | |||
CTIGX | 15.58 | -0.30 | -1.89% |
Calamos Timpani SMID Growth I | |||
ALVOX | 111.67 | -2.37 | -2.08% |
Alger Capital Appreciation Ptfl I-2 | |||
SHSCX | 54.26 | -1.31 | -2.36% |
BlackRock Health Sciences Opps Inv C |